Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-17-063818
Filing Date
2017-10-26
Accepted
2017-10-26 06:01:16
Documents
6
Period of Report
2017-10-26

Document Format Files

Seq Description Document Type Size
1 6-K a17-24478_16k.htm 6-K 15501
2 EX-99.1 a17-24478_1ex99d1.htm EX-99.1 57623
3 GRAPHIC g244781mmi001.jpg GRAPHIC 1890
4 GRAPHIC g244781mmi002.jpg GRAPHIC 1887
5 GRAPHIC g244781mmi003.jpg GRAPHIC 1890
6 GRAPHIC g244781mmi004.jpg GRAPHIC 1889
  Complete submission text file 0001104659-17-063818.txt   85264
Mailing Address INDUSTRIEPARK ZQIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052
Business Address INDUSTRIEPARK ZQIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052 32 (9) 310 34 00
ARGENX SE (Filer) CIK: 0001697862 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38097 | Film No.: 171154590
SIC: 2836 Biological Products, (No Diagnostic Substances)